NCT01365507 - Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens | Biotech Hunter

Enrollment

276

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec/insulin aspart

Insulin degludec/insulin aspart injected subcutaneously (under the skin) once daily. Dose individually adjusted.

Trial Locations (42)

10400

Novo Nordisk Investigational Site, Bangkok

11787

Novo Nordisk Investigational Site, Smithtown

16150

Novo Nordisk Investigational Site, Kota Bharu, Kelantan

16247

Novo Nordisk Investigational Site, Suwon

20782

Novo Nordisk Investigational Site, Hyattsville

21901

Novo Nordisk Investigational Site, North East

23606

Novo Nordisk Investigational Site, Newport News

27203

Novo Nordisk Investigational Site, Asheboro

30000

Novo Nordisk Investigational Site, Nakhon Ratchasima

32258

Novo Nordisk Investigational Site, Jacksonville

33027

Novo Nordisk Investigational Site, Pembroke Pines

34096

Novo Nordisk Investigational Site, Istanbul

34718

Novo Nordisk Investigational Site, Istanbul

34890

Novo Nordisk Investigational Site, Istanbul

42003

Novo Nordisk Investigational Site, Paducah

42431

Novo Nordisk Investigational Site, Madisonville

44650

Novo Nordisk Investigational Site, Guadalajara

46150

Novo Nordisk Investigational Site, Kuala Selangor

48235

Novo Nordisk Investigational Site, Detroit

53209

Novo Nordisk Investigational Site, Milwaukee

55123

Novo Nordisk Investigational Site, Eagan

64460

Novo Nordisk Investigational Site, Monterrey

75230

Novo Nordisk Investigational Site, Dallas

75246

Novo Nordisk Investigational Site, Dallas

77070

Novo Nordisk Investigational Site, Houston

77478

Novo Nordisk Investigational Site, Sugar Land

79423

Novo Nordisk Investigational Site, Lubbock

80100

Novo Nordisk Investigational Site, Johor Bahru

90057

Novo Nordisk Investigational Site, Los Angeles

91763

Novo Nordisk Investigational Site, Montclair

91978

Novo Nordisk Investigational Site, Spring Valley

92262

Novo Nordisk Investigational Site, Palm Springs

94520-1926

Novo Nordisk Investigational Site, Concord

32209-6511

Novo Nordisk Investigational Site, Jacksonville

41017-3464

Novo Nordisk Investigational Site, Crestview Hills

48085-5524

Novo Nordisk Investigational Site, Troy

00961

Novo Nordisk Investigational Site, Bayamón

08308

Novo Nordisk Investigational Site, Seoul

110-746

Novo Nordisk Investigational Site, Seoul

150-950

Novo Nordisk Investigational Site, Seoul

158-710

Novo Nordisk Investigational Site, Seoul

07058

Novo Nordisk Investigational Site, Antalya